Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

155.64
Delayed Data
As of Jan 27
 +0.09 / +0.06%
Today’s Change
125.36
Today|||52-Week Range
169.98
-2.30%
Year-to-Date
Nepsis Inc. Buys 2, Sells 3 in 4th Quarter
Jan 25 / GuruFocus News - Paid Partner Content
2 Promising New Growth Stocks to Watch in 2023
Jan 23 / MotleyFool.com - Paid Partner Content
Strength Seen in Catalyst (CPRX): Can Its 9.2% Jump Turn into More Strength?
Jan 25 / Zacks.com - Paid Partner Content
Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival
Jan 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close155.55
Today’s open155.20
Day’s range153.63 - 156.76
Volume15,368
Average volume (3 months)550,646
Market cap$9.9B
Data as of 3:59pm ET, 01/27/2023

Growth & Valuation

Earnings growth (last year)-228.94%
Earnings growth (this year)+9.01%
Earnings growth (next 5 years)+7.04%
Revenue growth (last year)+30.91%
P/E ratioNM
Price/Sales2.46
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+1.38+2.64%
RDYDr Reddy's Laborator...0.000.00%
SRPTSarepta Therapeutics...-0.02-0.02%
RGENRepligen Corp0.000.00%
Data as of 4:00pm ET, 01/27/2023

Financials

Next reporting dateFebruary 28, 2023
EPS forecast (this quarter)$4.47
Annual revenue (last year)$3.1B
Annual profit (last year)-$329.7M
Net profit margin-10.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts